Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care [Genetic Testing for Cancer]

Conclusion The frequency of mutations in most breast cancer panel genes among individuals selected for possible hereditary breast cancer is low and, in many cases, similar or even lower than that observed among cancer-free population controls. Although multigene panels can significantly aid in cancer risk management and expedite clinical translation of new genes, they equally have the potential to provide clinical misinformation and harm at the individual level if the data are not interpreted cautiously.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Tags: Epidemiology Genetic Testing for Cancer Source Type: research